APPLICATION
ANDA205318
TYPE
ANDA
ORIGINAL APPROVAL
2016-02-01
LATEST ACTION
2018-11-02
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
LIDOCAINEPrescription
LIDOCAINE 5% · OINTMENT · TOPICAL
Approval history
2018-11-02Labeling · Supplement 3 · standardAP
2017-07-17Manufacturing (CMC) · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.